Literature DB >> 26841348

Tissue microarray use for immunohistochemical study of ameloblastoma.

Rodrigo Neves-Silva1, Felipe Paiva Fonseca1, Adriana Souza de Jesus2, Hélder Antônio Rebelo Pontes2, André Caroli Rocha3, Thais Bianca Brandão1, Pablo Agustin Vargas1,4, Márcio Ajudarte Lopes1, Oslei Paes de Almeida1, Alan Roger Santos-Silva5.   

Abstract

BACKGROUND: Ameloblastoma is a locally aggressive odontogenic tumor with high rates of recurrence. To better understand the molecular basis of ameloblastoma, tissue microarray (TMA) may represent a useful tool. However, despite TMA has been considered a high-throughput technique for different human neoplasms, it remains to be validated in the ameloblastoma context. Therefore, the objective of this study was to validate TMA for immunohistochemical study of ameloblastoma, determining its most appropriate design.
METHODS: Forty cases of ameloblastoma were manually distributed in two TMA blocks assembled in triplicate containing 1.0- and 2.0-mm cores (20 cases each). Immunohistochemistry for cytokeratins 14 and 19, and Bcl-2 and Ki-67 was performed, and semiquantitative analysis was performed. Results obtained with TMA sections were compared to their corresponding conventional whole-section slides (CWSS).
RESULTS: Kappa statistical test demonstrated that both 1.0- and 2.0-mm cores assessed as duplicate or triplicate significantly correlated with CWSS, with higher levels obtained using Ki67 (k = 0.98, 0.97, 0.88, 0.87) and CK19 (k = 0.62, 0.58, 0.85, 0.85). There was no significant difference between 1.0- and 2.0-mm cores, and between duplicate and triplicate values. 1.0-mm TMA showed a higher index of core loss (33.74% vs. 4.99%).
CONCLUSION: Using a manual arrayer, it was demonstrated that 1.0-mm TMA arranged in duplicate is a valid method for ameloblastoma immunohistochemical study with satisfactory levels of agreement between TMA cylinders and CWSS.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Bcl-2; Ki67; ameloblastoma; cytokeratin; tissue microarray

Mesh:

Substances:

Year:  2016        PMID: 26841348     DOI: 10.1111/jop.12428

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  3 in total

1.  Tissue microarray is suitable for scientific biomarkers studies in endometrial cancer.

Authors:  Nicole C M Visser; Anneke A M van der Wurff; Johanna M A Pijnenborg; Leon F A G Massuger; Johan Bulten; Iris D Nagtegaal
Journal:  Virchows Arch       Date:  2018-02-09       Impact factor: 4.064

2.  HIF-1α Is Associated with Resistance to Hypoxia-Induced Apoptosis in Ameloblastoma.

Authors:  Katherine Julissa Palma Valladares; Karolyny Martins Balbinot; Antonia Taiane Lopes de Moraes; Maria Sueli da Silva Kataoka; Aline Maria Pereira Cruz Ramos; Rommel Thiago Jucá Ramos; Artur Luiz da Costa da Silva; Ricardo Alves Mesquita; David Normando; Sérgio de Melo Alves Júnior; João de Jesus Viana Pinheiro
Journal:  Int J Dent       Date:  2021-12-27

3.  A Novel lncRNA ENST00000512916 Facilitates Cell Proliferation, Migration and Cell Cycle Progression in Ameloblastoma.

Authors:  Yan Sun; Xing Niu; Guannan Wang; Xue Qiao; Lijie Chen; Ming Zhong
Journal:  Onco Targets Ther       Date:  2020-02-19       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.